Biomarkers for assessing liver function
US8455220B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 7, 2007 |
| Grant date | Jun 4, 2013 |
| Priority date | — |
| Expiry date | Oct 17, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/085
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method for assessing liver function in an individual, which method comprises determining the level of methylarginine(s) (such as ADMA and/or SDMA) and the ratio of ischemia modified albumin (IMA): albumin ratio (IMAR) in the individual, thereby to assess liver function in the individual.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.